Brief: Cantargia Publishes Preclinical Results Highlighting Can10's Potential To Inhibit Vascular Inflammation
19/05/2025 06:34
May 19 (Reuters) - Cantargia AB CANTA.ST: PUBLISHES PROMISING PRECLINICAL RESULTS HIGHLIGHTING CAN10'S POTENTIAL TO INHIBIT VASCULAR INFLAMMATION IL1RAP EXPRESSION POSITIVELY CORRELATES WITH INFLAMMATORY MARKERS IN HUMAN ATHEROSCLEROTIC PLAQUES IL1RAP BLOCKING ANTIBODIES INHIBIT ENDOTHELIAL ACTIVATION, NEUTROPHIL ADHESION INDUCED BY IL-1, IL-33 AND IL-36 Source text: ID:nMFN45PpMN Further company coverage: CANTA.ST (Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))